![](/img/cover-not-exists.png)
The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone
Greet Van den Berghe, Robert C. Baxter, Frank Weekers, Pieter Wouters, Cyril Y. Bowers, Ali Iranmanesh, Johannes D. Veldhuis, Roger BouillonVolume:
56
Year:
2002
Language:
english
Pages:
15
DOI:
10.1046/j.1365-2265.2002.01255.x
File:
PDF, 229 KB
english, 2002